History Market Opportunity Press Room Management Scientific Advisory	Re-Usable Single Use Sequal Maxtec	Arterial & Diabetic Ulcers Venous Ulcers Pressure Ulcers	Clinical Studies Case Studies Economic Value Guidelines Conferences Associations

Home About AOTI History Market Opportunity Press Room Management Scientific Advisory Products Re-Usable Single Use Wound Types Arterial & Diabetic Ulcers Venous Ulcers Pressure Ulcers Clinical Evidence Clinical Studies Economic Value Guidelines Associations Contact Us	Clinical Studies, Case Series & Abstracts AOTI is committed to providing the strongest scientific evidence as to the therapeutic benefits of our unique two2™ therapy. The following table and links detail the already extensive published evidence as to the utility of Topical Wound Oxygen. Additionally, the company is sponsoring three separate Randomized Controlled Trials encompassing over 250 patients, that are specifically investigating the clinical outcomes and cost saving benefits of our therapy in both Diabetic and Venous ulcer patients.  These studies are either ongoing or awaiting publication in leading journals.